Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sepsis × Gentamicins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroma, Acoustic 3 Surgical Wound Infection 2 Stomatitis 2 Nasopharyngeal Carcinoma 2 Sepsis 1 Neutropenia 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

telavancin 1 soybean oil, phospholipid emulsion 1 drotrecogin alfa activated 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1 Simvastatin 1 Saline Solution 1 Povidone-Iodine 1 Methods 1 Meropenem 1 Massage 1 Levofloxacin 1 Hydrochloric Acid 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gentamicins 1 Colistin 1 Colchicine 1 ClinOleic 1 Anti-Bacterial Agents 1 Amoxicillin-Potassium Clavulanate Combination 1 Alkaline Phosphatase 1 Acupuncture Therapy 1 2-Propanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡